Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001070081-20-000086
Filing Date
2020-04-27
Accepted
2020-04-27 16:15:31
Documents
5
Period of Report
2019-12-31
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 ptct2020proxy.htm DEF 14A 1367480
2 dyera05.jpg GRAPHIC 15626
3 g683229a01.jpg GRAPHIC 6822
4 proxygraphicv2.jpg GRAPHIC 529744
5 ptca01.jpg GRAPHIC 8644
  Complete submission text file 0001070081-20-000086.txt   2062930
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 20820132
SIC: 2834 Pharmaceutical Preparations